metformin and semaglutide for pcos improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized Semaglutide & Tirzepatide with PCOS:

In addition to the effects on weight loss and diabetes control both cardiovascular risk factors other mechanisms of action have been proposed for the entire class of GLP-1 agonists, Jayne Morgan, MD, a cardiologist and the executive director of Health and Community Education at the Piedmont Healthcare Corporation in Atlanta, GA, not involved in the study, told MNT

The ratio of fat to lean tissue shifts favorably, with lean body mass proportion increasing by approximately 3.0 percent

Vitamin B12 is water-soluble, and excess amounts are generally excreted through urine

Retatrutide targets three, GLP-1, GIP, and glucagon